Y Li, D Li, H Lin, D Wang, J Zhao, Z Wang… - Journal of Controlled …, 2025 - Elsevier
Nanobodies (Nbs) hold great promise as next-generation cancer immunotherapies, but their
efficacy is hindered by their poor pharmacokinetics and the inability to trigger Fc-mediated …